Changes in serum levels of miR-21, miR-210, and miR-373 in HER2-positive breast cancer patients undergoing neoadjuvant therapy: a translational research project within the Geparquinto trial
Crossref DOI link: https://doi.org/10.1007/s10549-014-3079-3
Published Online: 2014-08-03
Published Print: 2014-08
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Müller, Volkmar
Gade, Stephan
Steinbach, Bettina
Loibl, Sibylle
von Minckwitz, Gunter
Untch, Michael
Schwedler, Kathrin
Lübbe, Kristina
Schem, Christian
Fasching, Peter A.
Mau, Christine
Pantel, Klaus
Schwarzenbach, Heidi
Text and Data Mining valid from 2014-08-01